Ultragenyx Pharmaceutical Inc.
RARE
$35.11
-$0.87-2.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.95% | 0.41% | -20.46% | 85.36% | -28.61% |
| Total Receivables | -16.80% | 29.97% | -12.17% | 7.79% | 34.85% |
| Inventory | 2.28% | 3.86% | 7.97% | 11.78% | 5.71% |
| Prepaid Expenses | 49.50% | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 24.55% | -87.32% | 2.41% | 10.25% | 2,266.88% |
| Total Current Assets | -14.44% | 2.19% | -17.11% | 61.86% | -18.60% |
|
|
|||||
| Total Current Assets | -14.44% | 2.19% | -17.11% | 61.86% | -18.60% |
| Net Property, Plant & Equipment | -10.47% | 6.97% | -2.25% | -2.25% | -9.33% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.00% | 8.11% | -0.78% | 0.73% | -0.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 67.76% | -30.99% | 0.19% | -10.34% | 77.50% |
| Total Assets | -12.74% | -2.27% | -4.95% | 23.82% | -12.34% |
|
|
|||||
| Total Accounts Payable | 22.43% | 7.69% | -39.82% | 45.97% | -2.71% |
| Total Accrued Expenses | -28.20% | 30.24% | 19.82% | 3.55% | -24.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.83% | 1.67% | 0.88% | 5.71% | 32.59% |
| Total Finance Division Other Current Liabilities | -21.78% | -11.48% | -- | -- | -- |
| Total Other Current Liabilities | -21.78% | -11.48% | -- | -- | -- |
| Total Current Liabilities | -15.25% | 20.75% | 4.45% | 11.11% | -12.43% |
|
|
|||||
| Total Current Liabilities | -15.25% | 20.75% | 4.45% | 11.11% | -12.43% |
| Long-Term Debt | -3.14% | -1.19% | -1.48% | -0.77% | -1.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.51% | 26.99% | -8.10% | -8.00% | -8.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.09% | 2.07% | 2.06% | 1.61% | 5.38% |
| Total Liabilities | -6.48% | 4.78% | -0.13% | 1.65% | -4.01% |
|
|
|||||
| Common Stock & APIC | 0.94% | 1.04% | 1.11% | 11.47% | 1.00% |
| Retained Earnings | -3.82% | -3.49% | -3.62% | -3.70% | -5.04% |
| Treasury Stock & Other | 46.97% | -171.76% | 181.83% | -154.06% | -166.62% |
| Total Common Equity | -43.50% | -26.39% | -19.79% | 208.29% | -49.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -43.50% | -26.39% | -19.79% | 208.29% | -49.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 0.00% | -- | -- | -- |
| Total Equity | -42.34% | -25.87% | -18.17% | 208.29% | -49.07% |
|
|
|||||